Goldman Sachs’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $44.8M | Buy |
769,875
+73,828
| +11% | +$3.4M | 0.01% | 1669 |
|
|
2025
Q4 | $31.2M | Sell |
696,047
-24,612
| -3% | -$1.03M | ﹤0.01% | 1941 |
|
|
2025
Q3 | $28.9M | Buy |
720,659
+158,859
| +28% | +$5.6M | ﹤0.01% | 1900 |
|
|
2025
Q2 | $17.6M | Buy |
561,800
+119,068
| +27% | +$3.88M | ﹤0.01% | 2238 |
|
|
2025
Q1 | $14.9M | Buy |
442,732
+32,486
| +8% | +$1.23M | ﹤0.01% | 2313 |
|
|
2024
Q4 | $16.1M | Sell |
410,246
-49,379
| -11% | -$2.04M | ﹤0.01% | 2344 |
|
|
2024
Q3 | $18.1M | Buy |
459,625
+95,452
| +26% | +$3.85M | ﹤0.01% | 2156 |
|
|
2024
Q2 | $14.2M | Buy |
364,173
+64,399
| +21% | +$2.57M | ﹤0.01% | 2174 |
|
|
2024
Q1 | $12.9M | Sell |
299,774
-76,528
| -20% | -$3.52M | ﹤0.01% | 2244 |
|
|
2023
Q4 | $17.3M | Buy |
376,302
+120,934
| +47% | +$4.27M | ﹤0.01% | 2034 |
|
|
2023
Q3 | $8.72M | Sell |
255,368
-19,712
| -7% | -$737K | ﹤0.01% | 2507 |
|
|
2023
Q2 | $10.6M | Sell |
275,080
-10,343
| -4% | -$411K | ﹤0.01% | 2397 |
|
|
2023
Q1 | $10.2M | Buy |
285,423
+1,882
| +0.7% | +$69.5K | ﹤0.01% | 2402 |
|
|
2022
Q4 | $11.2M | Sell |
283,541
-181,724
| -39% | -$6.62M | ﹤0.01% | 2479 |
|
|
2022
Q3 | $16.8M | Buy |
465,265
+168,951
| +57% | +$6.07M | ﹤0.01% | 2021 |
|
|
2022
Q2 | $9.01M | Sell |
296,314
-428,023
| -59% | -$12.9M | ﹤0.01% | 2612 |
|
|
2022
Q1 | $22.1M | Buy |
724,337
+552,943
| +323% | +$16.6M | 0.01% | 1969 |
|
|
2021
Q4 | $5.35M | Buy |
171,394
+75,409
| +79% | +$2.25M | ﹤0.01% | 3340 |
|
|
2021
Q3 | $1.47M | Sell |
95,985
-56,233
| -37% | -$977K | ﹤0.01% | 4456 |
|
|
2021
Q2 | $2.83M | Buy |
152,218
+16,999
| +13% | +$313K | ﹤0.01% | 3882 |
|
|
2021
Q1 | $2.42M | Sell |
135,219
-2,742
| -2% | -$46.5K | ﹤0.01% | 3794 |
|
|
2020
Q4 | $2.12M | Buy |
137,961
+75,995
| +123% | +$889K | ﹤0.01% | 3683 |
|
|
2020
Q3 | $686K | Buy |
61,966
+32,694
| +112% | +$385K | ﹤0.01% | 4306 |
|
|
2020
Q2 | $367K | Buy |
+29,272
| New | +$373K | ﹤0.01% | 4530 |
|
|
2020
Q1 | – | Sell |
-12,937
| Closed | -$170K | – | 5598 |
|
|
2019
Q4 | $170K | Buy |
12,937
+2,408
| +23% | +$25.3K | ﹤0.01% | 4935 |
|
|
2019
Q3 | $95K | Buy |
+10,529
| New | +$99.6K | ﹤0.01% | 4971 |
|
|
2019
Q2 | – | Sell |
-12,246
| Closed | -$124K | – | 5381 |
|
|
2019
Q1 | $124K | Sell |
12,246
-417
| -3% | -$3.54K | ﹤0.01% | 4896 |
|
|
2018
Q4 | $80K | Buy |
+12,663
| New | +$113K | ﹤0.01% | 5038 |
|
|
2015
Q2 | – | Sell |
-11,999
| Closed | -$202K | – | 7461 |
|
|
2015
Q1 | $202K | Sell |
11,999
-8,801
| -42% | -$163K | ﹤0.01% | 6012 |
|
|
2014
Q4 | $411K | Buy |
+20,800
| New | +$305K | ﹤0.01% | 5477 |
|
Other funds holding XENE
ACA
DCM
PCH
